Literature DB >> 7983195

Genetic discrimination and screening for hemochromatosis.

J S Alper1, L N Geller, C I Barash, P R Billings, V Laden, M R Natowicz.   

Abstract

Recent advances in tests for the genotype for hemochromatosis and suggestions that the tests be used in mass screening programs for the disease raise the possibility of a large increase in the incidence of discrimination against people who are found to be homozygous for hemochromatosis. This paper presents cases of genetic discrimination drawn from a study of discrimination against people with a variety of genetic conditions. The cases discussed here involve employment and several types of insurance discrimination against people diagnosed with hemochromatosis who either are currently asymptomatic or whose condition is controlled by means of phlebotomies. There is no justification for these types of discrimination since people with controlled hemochromatosis suffer no excess mortality or morbidity. Our study suggests that genetic discrimination is already a serious problem and that any proposed screening program for hemochromatosis or other genetic condition must consider and attempt to mitigate its effects.

Entities:  

Keywords:  Americans with Disabilities Act 1990; Empirical Approach; Genetics and Reproduction; Health Care and Public Health

Mesh:

Year:  1994        PMID: 7983195

Source DB:  PubMed          Journal:  J Public Health Policy        ISSN: 0197-5897            Impact factor:   2.222


  12 in total

1.  Laws restricting health insurers' use of genetic information: impact on genetic discrimination.

Authors:  M A Hall; S S Rich
Journal:  Am J Hum Genet       Date:  2000-01       Impact factor: 11.025

2.  Diabetes and HFE mutations: cause or coincidence?

Authors:  Linda E Pinsky; Giuseppina Imperatore; Wylie Burke
Journal:  West J Med       Date:  2002-03

3.  Distinguishing genetic from nongenetic medical tests: some implications for antidiscrimination legislation.

Authors:  Joseph S Alper; Jon Beckwith
Journal:  Sci Eng Ethics       Date:  1998-04       Impact factor: 3.525

4.  Individual, family, and societal dimensions of genetic discrimination: a case study analysis.

Authors:  Lisa N Geller; Joseph S Alper; Paul R Billings; Carol I Barash; Jonathan Beckwith; Marvin R Natowicz
Journal:  Sci Eng Ethics       Date:  1996-01       Impact factor: 3.525

5.  Civilian and military genetics: nondiscrimination policy in a post-GINA world.

Authors:  Susannah Baruch; Kathy Hudson
Journal:  Am J Hum Genet       Date:  2008-10       Impact factor: 11.025

6.  Normal iron metabolism and the pathophysiology of iron overload disorders.

Authors:  Chiang W Siah; John Ombiga; Leon A Adams; Debbie Trinder; John K Olynyk
Journal:  Clin Biochem Rev       Date:  2006-02

Review 7.  Population screening for hemochromatosis: has the time finally come?

Authors:  J C Barton; R T Acton
Journal:  Curr Gastroenterol Rep       Date:  2000-02

8.  Engagement with genetic discrimination: concerns and experiences in the context of Huntington disease.

Authors:  Yvonne Bombard; Elizabeth Penziner; Oksana Suchowersky; Mark Guttman; Jane S Paulsen; Joan L Bottorff; Michael R Hayden
Journal:  Eur J Hum Genet       Date:  2007-10-24       Impact factor: 4.246

9.  Perception, experience, and response to genetic discrimination in Huntington's disease: the Australian results of The International RESPOND-HD study.

Authors:  Anita M Y Goh; Edmond Chiu; Olga Yastrubetskaya; Cheryl Erwin; Janet K Williams; Andrew R Juhl; Jane S Paulsen
Journal:  Genet Test Mol Biomarkers       Date:  2013-01-04

10.  Fear of health insurance loss among individuals at risk for Huntington disease.

Authors:  Emily Oster; E Ray Dorsey; Jan Bausch; Aileen Shinaman; Elise Kayson; David Oakes; Ira Shoulson; Kimberly Quaid
Journal:  Am J Med Genet A       Date:  2008-08-15       Impact factor: 2.802

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.